Applied Therapeutics Inc (NASDAQ: APLT) is -36.78% lower on its value in year-to-date trading and has touched a low of $0.54 and a high of $10.62 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The APLT stock was last observed hovering at around $0.58 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $0.54, the stock is -9.93% and -38.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.69 million and changing -6.07% at the moment leaves the stock -89.12% off its SMA200. APLT registered -80.53% loss for a year compared to 6-month loss of -90.72%. The firm has a 50-day simple moving average (SMA 50) of $1.04124 and a 200-day simple moving average (SMA200) of $4.99506.
The stock witnessed a -21.66% gain in the last 1 month and extending the period to 3 months gives it a -94.64%, and is -10.85% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.41% over the week and 11.24% over the month.
Distance from 52-week low is -0.48% and -94.90% from its 52-week high.
with sales reaching $100k over the same period.The EPS is expected to grow by 1.41% this year, but quarterly earnings will post -94.66% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 116.36M, and float is at 91.42M with Short Float at 23.06%.
The top institutional shareholder in the company is FRANKLIN RESOURCES INC with over 10.21 million shares valued at $47.69 million. The investor’s holdings represent 70.7533 of the APLT Shares outstanding. As of 2024-06-30, the second largest holder is VR ADVISER, LLC with 9.54 million shares valued at $44.57 million to account for 66.1112 of the shares outstanding. The other top investors are PROPEL BIO MANAGEMENT, LLC which holds 6.57 million shares representing 45.5009 and valued at over $30.67 million, while VESTAL POINT CAPITAL, LP holds 37.618 of the shares totaling 5.43 million with a market value of $25.36 million.
Applied Therapeutics Inc (APLT) Insider Activity
The most recent transaction is an insider sale by Funtleyder Leslie D.,. SEC filings show that Funtleyder Leslie D. sold 22,950 shares of the company’s common stock on Feb 06 ’25 at a price of $0.61 per share for a total of $14000.0. Following the sale, the insider now owns 0.4 million shares.
Applied Therapeutics Inc disclosed in a document filed with the SEC on Feb 06 ’25 that Perfetti Riccardo (Chief Medical Officer) sold a total of 86,078 shares of the company’s common stock. The trade occurred on Feb 06 ’25 and was made at $0.61 per share for $52508.0. Following the transaction, the insider now directly holds 0.9 million shares of the APLT stock.
Still, SEC filings show that on Feb 06 ’25, Chinoporos Constantine disposed off 28,117 shares at an average price of $0.61 for $17151.0. The insider now directly holds 271,883 shares of Applied Therapeutics Inc (APLT).
